• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Difficult to Remove (1528); Patient-Device Incompatibility (2682)
Patient Problems Fatigue (1849); Headache (1880); Hearing Impairment (1881); Vertigo (2134); Visual Impairment (2138); Myalgia (2238); Arthralgia (2355); No Code Available (3191)
Event Date 06/15/2016
Event Type  Injury  
Event Description
This spontaneous case was reported by a gynecologist/obstetrician and describes the occurrence of allergy to metals ("nickel allergy") in a (b)(6) female patient who had essure inserted for female sterilization.The occurrence of additional non-serious events is detailed below.The patient's past medical history included parity 2 and general anesthesia.Patient had no known allergies.Previously administered products included for an unreported indication: iud and pill.Past adverse reactions to the above products included drug intolerance with pill.On (b)(6) 2016, the patient had essure inserted.On (b)(6) 2016, the patient experienced allergy to metals (seriousness criteria medically significant and intervention required), musculoskeletal pain ("joint and muscle pain"), fatigue ("fatigue"), visual impairment ("visual problems"), auditory disorder ("hearing problems"), gout ("gout"), migraine ("migraines") and vertigo ("vertigo").On an unknown date, the patient experienced complication of device removal ("essure surgical removal difficulties/complications").The patient was treated with surgery (salpingectomy and bilateral corn resection - essure removed via laparoscopy).Essure was removed.At the time of the report, the allergy to metals, musculoskeletal pain, fatigue, visual impairment, auditory disorder, gout, migraine and vertigo was resolving and the complication of device removal outcome was unknown.The reporter provided no causality assessment for allergy to metals, auditory disorder, complication of device removal, fatigue, gout, migraine, musculoskeletal pain, vertigo and visual impairment with essure.The reporter commented: nickel allergy was not known prior to insertion.Bilateral corn resection necessary due to essure surgical removal difficulties/complications.No post-operative complications were noted.Essure symptoms improved after removal, but no disappearance of all signs.Patient was very satisfied with the surgery.No x-ray after essure removal.Diagnostic results (normal ranges are provided in parenthesis if available): allergy test - in 2016: nickel allergy confirmed.X-ray - on (b)(6) 2016: essure in correct position.The list of device similar incidents contains essure reports received by bayer and older cases received by conceptus coded with the same meddra preferred term.In this particular case a search in the database was performed on 27_jul_2017 for the following meddra preferred term: allergy to metals: the analysis in the global safety database revealed 272 cases.Bayer is closely monitoring the benefit-risk profile of essure.A recent cumulative review of all available data on essure has not yielded any new safety signal with regard to this meddra pt.Incident.No lot number or sample available for investigation.There is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k. shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981-0915
MDR Report Key6793791
MDR Text Key82672493
Report Number2951250-2017-02894
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Physician
Type of Report Initial
Report Date 08/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/26/2017
Initial Date FDA Received08/15/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age35 YR
-
-